Unichem Laboratories share rises 8% on US FDA approval for Apremilast tablets The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE BusinessToday.In | February 19, 2021 | Updated 17:12 IST Unichem Labs share stands higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages. Unichem Laboratories share price rose nearly 8 percent today after United States Food and Drug Administration's (US FDA) awarded approval for its Apremilast tablets. The stock has gained 6.9% in the last 4 days. The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE. Unichem Labs share stands higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages. The share has gained 131.55% in one year and risen 22.66% since the beginning of this year. Later, the small cap stock closed 4.94% or Rs 15.10 higher at Rs 320.70.